-
I649978-5mgIDO-IN-5 (NLG-1489) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, compound 1489, has an IC 50 of 1-10 μM.In VitroIDO-IN-5 (Compound 1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50
-
I649437-10mgIDO-IN-6 (NLG-1486) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, Compound 1486, has an IC 50 of <:1 μM.In VitroIDO-IN-6 (Compound 1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50
-
I649437-1mgIDO-IN-6 (NLG-1486) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, Compound 1486, has an IC 50 of <:1 μM.In VitroIDO-IN-6 (Compound 1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50
-
I649437-5mgIDO-IN-6 (NLG-1486) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, Compound 1486, has an IC 50 of <:1 μM.In VitroIDO-IN-6 (Compound 1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50
-
I655857-1mlIDO-IN-6 (NLG-1486) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, Compound 1486, has an IC 50 of <:1 μM.In VitroIDO-IN-6 (Compound 1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50
-
I649869-10mgIDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, compound 1487, has an IC 50 of 1-10 μM.In VitroIDO-IN-8 (Compound 1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50
-
I649869-1mgIDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, compound 1487, has an IC 50 of 1-10 μM.In VitroIDO-IN-8 (Compound 1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50
-
I649869-5mgIDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, compound 1487, has an IC 50 of 1-10 μM.In VitroIDO-IN-8 (Compound 1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50
-
I656034-1mlIDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, compound 1487, has an IC 50 of 1-10 μM.In VitroIDO-IN-8 (Compound 1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50
-
I649569-10mgIDO/TDO-IN-1 (compound 25) is a highly potent and orally active dual indoleamine-2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) inhibitor with IC 50 s of 9.7 and 47 nM, respectivelyIn VitroIDO/TDO-IN-1 inhibits IDO in the Hela cell line
-
I649569-25mgIDO/TDO-IN-1 (compound 25) is a highly potent and orally active dual indoleamine-2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) inhibitor with IC 50 s of 9.7 and 47 nM, respectivelyIn VitroIDO/TDO-IN-1 inhibits IDO in the Hela cell line
-
I649569-5mgIDO/TDO-IN-1 (compound 25) is a highly potent and orally active dual indoleamine-2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) inhibitor with IC 50 s of 9.7 and 47 nM, respectivelyIn VitroIDO/TDO-IN-1 inhibits IDO in the Hela cell line